Toward More Equitable Breast Cancer Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toward More Equitable Breast Cancer Outcomes

Published:2024-06-11 Issue:22 Volume:331 Page:1896
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Elmore Joann G.¹,Lee Christoph I.²³⁴

Affiliation:

1. Department of Medicine, UCLA National Clinician Scholar Program, David Geffen School of Medicine at UCLA, Los Angeles, California

2. Department of Radiology, University of Washington School of Medicine

3. Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle

4. Fred Hutchinson Cancer Center, Seattle, Washington

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2818287/jama_elmore_2024_ed_240031_1717088673.32818.pdf

Reference10 articles.

1. Screening for breast cancer: US Preventive Services Task Force recommendation statement.;US Preventive Services Task Force;JAMA,2024

2. Screening performance of digital breast tomosynthesis vs digital mammography in community practice by patient age, screening round, and breast density.;Lowry;JAMA Netw Open,2020

3. Breast cancer statistics, 2022.;Giaquinto;CA Cancer J Clin,2022

4. Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US Preventive Services Task Force.;Trentham-Dietz;JAMA,2024

5. Comparative access to and use of digital breast tomosynthesis screening by women’s race/ethnicity and socioeconomic status.;Lee;JAMA Netw Open,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case Study Identifying Barriers to Breast Cancer Screening and Strategies for Improved Access and Participation in an Underserved Community;Academic Radiology;2024-07

2. Breast cancer screening from age 40 in the US;BMJ;2024-06-24

3. Design, synthesis, and antiproliferative screening of new quinoline derivatives bearing a cis-vinyl triamide motif as apoptosis activators and EGFR-TK inhibitors;RSC Advances;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3